Imperial College London
Portrait Picture

DrGeorgiosNteliopoulos

Faculty of Medicine, Department of Surgery & Cancer

Research Associate Biomarker
 
 
 
//

Contact

 

georgios.nteliopoulos04

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Nteliopoulos:2016,
author = {Nteliopoulos, G and Bazeos, A and Gerrard, G and Claudiani, S and Curry, E and Alikian, M and Foong, HE and Foroni, L and Apperley, JF},
publisher = {AMER SOC HEMATOLOGY},
title = {Somatic Mutations in Epigenetic Modifiers Identified Using Next Generation Sequencing (NGS) in Diagnostic Samples of CML-CP Can Predict Poor Outcome on Imatinib Which Is Abrogated By Frontline 2G-TKI Therapy},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394446804096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Nteliopoulos,G
AU  - Bazeos,A
AU  - Gerrard,G
AU  - Claudiani,S
AU  - Curry,E
AU  - Alikian,M
AU  - Foong,HE
AU  - Foroni,L
AU  - Apperley,JF
PB  - AMER SOC HEMATOLOGY
PY  - 2016///
SN  - 0006-4971
TI  - Somatic Mutations in Epigenetic Modifiers Identified Using Next Generation Sequencing (NGS) in Diagnostic Samples of CML-CP Can Predict Poor Outcome on Imatinib Which Is Abrogated By Frontline 2G-TKI Therapy
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394446804096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER  -
Download